Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q1 2023 financial results on
AdaptHealth Corp. (NASDAQ: AHCO) reported its financial results for Q4 and fiscal year 2022, highlighting a net revenue increase of 21% year-over-year, reaching $3.160 billion to $3.240 billion for 2023. Despite a strong revenue growth of 11.1% in Q4, net income fell to $69.3 million, down from $156.2 million in 2021. Adjusted EBITDA in 2022 was $593.8 million, while Q4 EBITDA dropped to $146.0 million. The company aims to implement cost containment programs to align with updated guidance. CEO Steve Griggs emphasized strategic advancements, including a merger integration with AeroCare and commitment to healthcare solutions for chronic patients.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its fourth quarter and full year 2022 financial results on February 28, 2023, prior to market opening. The management team will hold a teleconference at 8:30 a.m. ET to discuss financial metrics and business activities with analysts and investors. Interested parties can join the call via phone, using the specified domestic and international numbers, or by registering for the webcast. AdaptHealth provides patient-centered healthcare-at-home solutions, including home medical equipment and supplies, serving approximately 3.9 million patients annually through a network of over 750 locations across 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) announced its initial guidance for fiscal year 2023, projecting net revenue between
AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:00 PM PT. The presentation will be available via a live webcast on the company's investor website. AdaptHealth specializes in patient-centered healthcare-at-home solutions, providing a range of medical equipment and supplies to help manage chronic conditions. The company serves approximately 3.9 million patients annually across the United States through a network of 750 locations.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the BofA Securities Home Care Conference on December 5 at 2:00 pm ET. CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will represent the company. A live webcast and replay will be available on AdaptHealth's investors page, with attendees encouraged to register early. AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 3.9 million patients annually across 750 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported record net revenue of $756.5 million for Q3 2022, up 15.8% from $653.3 million in Q3 2021. However, net income dropped to $16.1 million ($0.11 per share) from $58.1 million ($0.20 per share) year-over-year. Adjusted EBITDA increased slightly to $160.2 million, while cash flow from operations rose significantly to $107.0 million. The company updated its fiscal year 2022 guidance, projecting net revenue between $2.950 billion and $3.010 billion, reflecting strong demand in the healthcare-at-home market.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its third quarter 2022 financial results before the market opens on November 8, 2022. Management will hold a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. AdaptHealth is a leader in providing healthcare-at-home solutions, serving around 3.9 million patients annually through over 750 locations in 47 states, focusing on home medical equipment, medical supplies, and related services.
FAQ
What is the current stock price of AdaptHealth (AHCO)?
What is the market cap of AdaptHealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
